Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.45
Delayed Data
As of 2:34pm ET
 +0.12 / +9.02%
Today’s Change
0.84
Today|||52-Week Range
8.46
-43.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.0M854.0K896.0K854.0K
 
 
 
 
 
Depreciation And Amortization6.0K7.0K11.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.6M14.2M12.0M9.6M
 
 
 
 
 
Research And Development7.2M6.9M6.0M4.5M
 
 
 
 
 
Total Operating Expenses13.6M14.2M12.1M9.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.6M-13.3M-11.2M-8.8M
 
 
 
 
 
Extraordinary Credit333.0K0.00--0.00
 
 
Extraordinary Charge0.00-1.6M---89.0K
 
 
 
Interest Expense On Debt470.0K391.0K311.0K239.0K
 
 
 
 
 
Other Expenses-40.0K11.0K10.1M-31.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.8M-15.3M-1.3M-9.1M
 
 
 
 
 
Net Income-11.8M-15.3M-1.3M-9.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.2M60.5M63.0M67.6M
 
 
 
 
 
Shares To Calculate EPS Diluted61.9M60.5M63.0M67.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.25-$0.02-$0.13
 
 
 
 
 
EPS Diluted-$0.20-$0.25-$0.02-$0.13